Proteomic Profiling of Growth Hormone-Responsive Proteins in Human Peripheral Blood Leukocytes
Proteomic Profiling of Growth Hormone-Responsive Proteins in Human Peripheral Blood Leukocytes
复制标题
DOI:
10.1210/jc.2009-0778
复制
发表时间:
2009-08-01
影响因子:
5.8
通讯作者:
Baxter, Robert C.
中科院分区:
文献类型:
--
作者:
Chung, Liping;Nelson, Anne E.;Baxter, Robert C.
Context: GH is a known modulator of the immune system, but the effect of exogenous GH administration on white blood cell proteins has not been investigated. Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) is a powerful platform for the study of GH effects on immune system proteins.Objective: Our objective was to explore a novel approach for the detection of GH-responsive proteins in human leukocytes by proteomic analysis using SELDI-TOF MS.Design: We conducted a randomized double-blind, placebo-controlled GH administration study of 8 wk treatment followed by 6 wk washout. Pre- and posttreatment samples from 30 subjects were used for biomarker discovery.Setting: The study was performed at a clinical research facility.Participants: We studied 30 recreationally trained healthy athletes.Intervention: Subjects received either recombinant human GH (2 mg/d sc; n = 22) or placebo (n = 8) for 8 wk.Main Outcome Measures: Proteomic profiles were determined using CM10 weak cation-exchange protein chips, and some GH-regulated proteins were purified and identified by mass spectrometry and/or immunoblotting.Results: SELDI-TOF analysis revealed a number of GH-regulated peptides/proteins in the 3- to 22-kDa range that are either up-or down-regulated by GH. Several of these may be useful as biomarkers of GH action. The calcium-binding, proinflammatory calgranulins S100A8, S100A9, and S100A12 were all significantly down-regulated in response to GH treatment.Conclusion: This study illustrates the novel use of human leukocyte proteomic profiling by SELDI-TOF MS and reveals the negative regulation of proinflammatory S100 proteins by GH in human white blood cells. (J Clin Endocrinol Metab 94: 3038-3043, 2009)